Boston Scientific (BSX) EBIT Growth (1y) (2010 - 2026)
Powered by 
Analysis
Boston Scientific (BSX) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn | -17.50% |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn | 30.74% |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 22.08% |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn | 49.06% |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | 43.83% |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | 24.81% |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn | -95.55% |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 49.72% |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 16.18% |
| 10 | Zimmer Biomet Holdings | 18.23 Bn | 17.82 Bn | 1.54 Bn | 8.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.83% |
| Mar 31, 2026 | 19.54% |
| Dec 31, 2025 | 22.22% |
| Sep 30, 2025 | 42.97% |
| Jun 30, 2025 | 57.50% |
| Mar 31, 2025 | 36.44% |
| Dec 31, 2024 | 15.58% |
| Sep 30, 2024 | 5.77% |
| Jun 30, 2024 | 1.17% |
| Mar 31, 2024 | 22.28% |
| Dec 31, 2023 | 45.27% |
| Sep 30, 2023 | 93.58% |
| Jun 30, 2023 | 21.51% |
| Mar 31, 2023 | 18.45% |
| Dec 31, 2022 | 123.33% |
| Sep 30, 2022 | -7.49% |
| Jun 30, 2022 | 61.45% |
| Mar 31, 2022 | 25.95% |
| Dec 31, 2021 | 260.00% |
| Sep 30, 2021 | 288.78% |